CINCINNATI, March 13, 2026 /PRNewswire/ -- Today The Kroger Co. (NYSE: KR) and The Kroger Family of Pharmacies announced that as part of its continued commitment to expanding access to high-demand GLP-1 therapies, Zepbound® KwikPen – the newly launched, multi-dose delivery option of Eli Lilly's weight-management medication – is now available at participating Kroger pharmacies, bringing patients a more convenient option for obtaining their medication. Savings at the Pharmacy Counter The Kroger Family of Pharmacies honor manufacturer-sponsored programs, including Lilly's KwikPen Self-Pay Savings Card for Zepbound®, according to each program's eligibility requirements and terms and conditions.